phase i/iia study of bvac-c and durvalumab in hpv-positive recurrent cervical carcinoma
Published 4 months ago • 26 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
0:27
next steps in evaluating durvalumab and bvac-c for hpv-positive cervical cancer
-
1:08
combining durvalumab & bvac-c to enhance anti-tumor immune responses in recurrent cervical carcinoma
-
0:42
phase ii trial of cemiplimab and isa101b vaccine in hpv16 cervical cancer
-
40:15
cervical cancer hpv induced
-
16:30
hpv testing and same-day treatment for cervical screening and cancer prevention-a. vallely,mbbs, phd
-
3:09
m7824: a promising novel antibody for hpv-associated cancers
-
1:01:29
cervical & ovarian cancer: what you need to know?f
-
46:08
vasoplegia: the biology & new therapy - vitamin b-12
-
1:01
cervical cancer elimination english version
-
13:36
cervical cancer risk factors & management | @medvarsityonlineltd
-
0:15
702521a av howtochargethebattery final
-
0:29
beyond cervical cancer: what you need to know about hpv
-
0:28
beyond cervical cancer: what you need to know about hpv
-
0:15
obstetrics & gynaecology department - fv hospital
-
0:31
what if identifying hpv 31 could make the difference?
-
0:28
702519a av howtoturnontheafflovest final
-
1:10
dr. valdes-albini on the fda approval of adjuvant pertuzumab in her2 breast cancer
-
5:09
danielle was diagnosed with hpv and shares her story in preventing cervical cancer
-
4:09
case 2: maintenance in brca1/2wt, hr-proficient ovarian cancer